First description of mEAK-7 gene could suggest path toward therapies for cancer, other diseases

May 14, 2018 by Brianna Aldrich, University of California, Los Angeles
Credit: CC0 Public Domain

For years, researchers have known that a gene called EAK-7 plays an important role in determining how long worms will live. But it remained unclear whether the gene had a counterpart in humans and – if it did – how that human version would work.

Now, researchers led by UCLA's Dr. Paul Krebsbach are the first to characterize the mechanism of the human equivalent, which they call mammalian EAK-7, or mEAK-7.

Krebsbach, dean of the UCLA School of Dentistry and a professor of periodontics, led a team that found mEAK-7 regulates the molecular process, or "metabolic pathway," that dictates cell growth and human development.

The disruption of those processes is part of what causes cancer and other diseases, as well as some neurological disorders. Findings from the study could be a preliminary step toward new therapies that would work by slowing or blocking mEAK-7's , which in turn could potentially control the spread and growth of the responsible for those diseases.

The research was published in the journal Science Advances.

The researchers began studying EAK-7, the worm gene, in 2013, when Krebsbach was a faculty member at the University of Michigan. Knowing about its important role in worms, the team wanted to understand if it played a role in human biology, and whether it could provide insight on why certain human cells become .

Joe Nguyen, the study's lead author, said the team essentially stumbled on the link between EAK-7 and its human counterpart after their initial hypothesis about that connection proved incorrect.

Once they identified mEAK-7 in human cells, they screened several types of human cells—including and fibroblasts, the cells that form connective tissues and aid in wound healing—to better understand how the gene worked.

"We didn't detect mEAK-7 in any of those samples," said Nguyen, a D.D.S./Ph.D. candidate at the University of Michigan. "But what we did find was astonishing. When we tested for mEAK-7 in various cancer cells, we found that there was a notably high concentration of mEAK-7 protein."

The researchers ran a series of tests on human cells to see how mEAK-7 responded to a known as mTOR signaling, which regulates , growth, duplication and survival in humans.

According to Krebsbach, what they found was even more astonishing than the uncovering of mEAK-7 itself. The gene actually activated another biological process, which the researchers call an alternative pathway, one that was not as well understood at the molecular level as mTOR.

In effect, the discovery was like realizing that a driver (the mEAK-7 gene) had exited a freeway (the mTOR pathway) and chosen to travel little-known surface streets (the alternative pathway) to reach his destination.

"With the discovery of mEAK-7's activation of this alternative process, we demonstrated that cell metabolism, division and migration may be more dependent on the type of cell than was previously understood," Krebsbach said. "If we can find a way to control the duplication and migration of cells, including those responsible for human disease, we may be able to create opportunities for new therapies."

To support their findings, the scientists tested the significance of mEAK-7's role in cell proliferation and migration by inhibiting the gene in living . When they mutated mEAK-7 or removed it from those cells, there was a dramatic reduction of those processes. They also tested a scenario in which mEAK-7 was overexpressed in cells and found that the proliferation of those cells increased significantly.

"By chance, we have found that mEAK-7 is crucial for mTOR signaling and is required for cell proliferation and migration," said Jin Koo Kim, a UCLA Dentistry researcher. "By targeting mEAK-7, we could potentially control the diseases that hijack mTOR signaling through this alternative pathway."

Explore further: MicroRNA could help treat cancer and asthma

More information: Joe Truong Nguyen et al. Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration, Science Advances (2018). DOI: 10.1126/sciadv.aao5838

Related Stories

MicroRNA could help treat cancer and asthma

February 15, 2018

A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.

Mitochondria drive cell survival in times of need

September 21, 2017

McGill University researchers have discovered a mechanism through which mitochondria, the energy factory of our body's cells, play a role in preventing cells from dying when the cells are deprived of nutrients - a finding ...

Mystery molecule is a key to inhibiting colon cancer

December 12, 2016

Immunologists at St. Jude Children's Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., ...

Recommended for you

Prenatal forest fire exposure stunts children's growth

February 19, 2019

Forest fires are more harmful than previously imagined, causing stunted growth in children who were exposed to smoke while in the womb, according to new research from Duke University and the National University of Singapore.

'Astrocomb' opens new horizons for planet-hunting telescope

February 19, 2019

The hunt for Earth-like planets, and perhaps extraterrestrial life, just got more precise, thanks to record-setting starlight measurements made possible by a National Institute of Standards and Technology (NIST) "astrocomb."


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.